Shelby Walker
Trading-Equity at Becker Capital Management, Inc.
Net worth: - $ as of 2024-05-30
Shelby Walker active positions
| Companies | Position | Start | End |
|---|---|---|---|
Becker Capital Management, Inc.
 Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Trading-Equity | 1996-12-31 | - |
Career history of Shelby Walker
Former positions of Shelby Walker
| Companies | Position | Start | End |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 2018-02-28 | 2023-03-31 |
| Gingko Bioworks | General Counsel | 2016-04-30 | 2018-02-28 |
| DYAX CORP. | General Counsel | 2010-08-31 | 2016-05-31 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Novo Nordisk Pharma AG
 Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
Training of Shelby Walker
| The Johns Hopkins University | Graduate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Statistics
International
| United States | 8 |
| Switzerland | 3 |
Operational
| Corporate Officer/Principal | 3 |
| General Counsel | 3 |
| Graduate Degree | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 5 |
|---|---|
Becker Capital Management, Inc.
Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Finance |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
| Gingko Bioworks |
- Stock Market
- Insiders
- Shelby Walker
- Experience
